West Pharmaceutical Services - Stock

West Pharmaceutical Services Equity 2024

West Pharmaceutical Services Equity

2.88 B USD

Ticker

WST

ISIN

US9553061055

WKN

864330

In 2024, West Pharmaceutical Services's equity was 2.88 B USD, a 7.3% increase from the 2.68 B USD equity in the previous year.

West Pharmaceutical Services Aktienanalyse

What does West Pharmaceutical Services do?

West Pharmaceutical Services Inc. is a leading company in the development and manufacturing of innovative solutions for drug delivery and medical devices. The company has been in the market for over 100 years and is headquartered in Exton, Pennsylvania, USA. West operates in more than 50 countries worldwide and employs over 9,000 employees. The history of West Pharmaceutical Services begins in 1923, when Herman O. West founded the company in Philadelphia. Initially, West primarily produced rubber seals for canning jars and bottle closures. In the 1930s, West entered the production of plastic parts used in products such as tube radios. In the mid-1950s, West began to venture into the production of medical devices and accessories, such as syringe stoppers. Since then, the company has continuously expanded its product range and is now a leading provider of pharmaceutical delivery solutions. West is divided into three business segments: Healthcare Delivery Systems (HDS), Pharmaceutical Packaging Systems (PPS), and Contract Manufacturing Organization (CMO). The Healthcare Delivery Systems (HDS) segment specializes in the development and manufacturing of devices and systems for drug delivery. This includes syringes, injection devices, pen systems, nasal and inhalation devices. These products are developed in collaboration with various pharmaceutical companies to simplify and improve medication delivery. West has also developed many patented products, such as the "SmartDose" system, which enables accurate dosage delivery. The Pharmaceutical Packaging Systems (PPS) segment offers packaging solutions for pharmaceuticals. This includes injection vials, caps, and closures made of glass or plastic. PPS has also developed specialized packaging solutions, such as the "Ready Pack" solution, which packages sterile products in a safe and user-friendly environment. Another example is the "Westar UD" system, which allows for accurate and safe dosing of medications in ampoules. The Contract Manufacturing Organization (CMO) segment offers customized services, including design and development of packaging solutions and manufacturing of pharmaceuticals and medical devices. CMO manufacturing services include development, manufacturing, filling, and packaging of sterility products. West has a wide customer base in the pharmaceutical and biotech industry. The company works closely with its customers to develop customized solutions that meet their specific needs. West also has strong partnerships with other leading companies in the industry, such as Merck or Daikyo. Overall, West Pharmaceutical Services is distinguished by its high focus on quality and safety. The company places great emphasis on compliance with regulatory requirements and the use of safety-conscious manufacturing technologies. West also has its own quality control department, which ensures the high quality of its products and satisfies its customers. In summary, West Pharmaceutical Services is a leading provider of pharmaceutical delivery solutions and packaging solutions. With a wide portfolio of innovative products and services tailored to meet customer needs, West can provide safe and effective solutions to its customers worldwide. West Pharmaceutical Services ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing West Pharmaceutical Services's Equity

West Pharmaceutical Services's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding West Pharmaceutical Services's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating West Pharmaceutical Services's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

West Pharmaceutical Services's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in West Pharmaceutical Services’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about West Pharmaceutical Services Stock

What is the equity of West Pharmaceutical Services this year?

West Pharmaceutical Services has equity of 2.88 B USD this year.

What was the equity of West Pharmaceutical Services compared to the previous year?

The equity of West Pharmaceutical Services has increased/decreased by 7.3% increased compared to the previous year.

What impact does a high equity have on investors of West Pharmaceutical Services?

A high equity is advantageous for investors of West Pharmaceutical Services as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of West Pharmaceutical Services?

A low equity can be a risk for investors of West Pharmaceutical Services, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of West Pharmaceutical Services affect the company?

An increase in equity of West Pharmaceutical Services can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of West Pharmaceutical Services affect the company?

A reduction in equity of West Pharmaceutical Services can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of West Pharmaceutical Services?

Some factors that can affect the equity of West Pharmaceutical Services include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of West Pharmaceutical Services so important for investors?

The equity of West Pharmaceutical Services is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can West Pharmaceutical Services take to change the equity?

To change equity, West Pharmaceutical Services can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does West Pharmaceutical Services pay?

Over the past 12 months, West Pharmaceutical Services paid a dividend of 0.77 USD . This corresponds to a dividend yield of about 0.23 %. For the coming 12 months, West Pharmaceutical Services is expected to pay a dividend of 0.92 USD.

What is the dividend yield of West Pharmaceutical Services?

The current dividend yield of West Pharmaceutical Services is 0.23 %.

When does West Pharmaceutical Services pay dividends?

West Pharmaceutical Services pays a quarterly dividend. This is distributed in the months of December, February, May, August.

How secure is the dividend of West Pharmaceutical Services?

West Pharmaceutical Services paid dividends every year for the past 53 years.

What is the dividend of West Pharmaceutical Services?

For the upcoming 12 months, dividends amounting to 0.92 USD are expected. This corresponds to a dividend yield of 0.27 %.

In which sector is West Pharmaceutical Services located?

West Pharmaceutical Services is assigned to the 'Health' sector.

Wann musste ich die Aktien von West Pharmaceutical Services kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of West Pharmaceutical Services from 8/7/2024 amounting to 0.2 USD, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.

When did West Pharmaceutical Services pay the last dividend?

The last dividend was paid out on 8/7/2024.

What was the dividend of West Pharmaceutical Services in the year 2023?

In the year 2023, West Pharmaceutical Services distributed 0.73 USD as dividends.

In which currency does West Pharmaceutical Services pay out the dividend?

The dividends of West Pharmaceutical Services are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The West Pharmaceutical Services stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von West Pharmaceutical Services

Our stock analysis for West Pharmaceutical Services Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of West Pharmaceutical Services Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.